PUNIT DHILLON Insider Trading $ARTH Arch Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PUNIT DHILLON.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PUNIT DHILLON. PUNIT DHILLON is VP, Finance & Operations in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in ONCOSEC MEDICAL Inc ($ONCS) and President in ONCOSEC MEDICAL Inc ($ONCS) and President and CEO in ONCOSEC MEDICAL Inc ($ONCS.D) and CEO in Emerald Bioscience, Inc. ($NMUS) and Director in Nemus Bioscience, Inc. ($NMUS) and Director in Arch Therapeutics, Inc. ($ARTH).

PUNIT DHILLON in Arch Therapeutics, Inc.

Trading Symbol: ARTH
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PUNIT DHILLON: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 23 2019
$ARTH Market Capitalization: $92.55M
$ARTH Previous Close: $0.68

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PUNIT DHILLON in Arch Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARTH, GEB, ONCS, NMUS

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 23 2019ARTHArch Therapeutics, ...DHILLON PUNITDirectorOption ExerciseA0.23300,00068,760300,000
Jul 20 2018ARTHArch Therapeutics, ...DHILLON PUNITDirectorOption ExerciseA0.43200,00085,000200,000

Page:   1